As companies rush to open or buy ketamine clinics to treat mental health conditions, concern is growing about protocols, staffing levels and the safety of the newest approach: take-home ketamine.
The name “MindSite News” is used with the express permission of Mindsight Institute, an educational organization offering online learning and in-person workshops in the field of mental health and wellbeing. MindSite News and Mindsight Institute are separate, unaffiliated entities that are aligned in making science accessible and promoting mental health globally.